AMSBIO, a supplier of advanced 3D tools to the life science community, recently participated in a '3D Cell Culture in Drug Discovery and Disease Modeling' webinar. Due to huge demand, the webinar which aired on 22nd May, has been reproduced in an on-demand version.
Driven by the limitations of 2D cell cultures - scientists search for alternative solutions that mirror the environment experienced by normal cells in the body and replicate complex tissue structures and in vivo-like morphology. The '3D Cell Culture in Drug Discovery and Disease Modeling' webinar focuses on discussing the latest advances in 3D technology and its contribution to conducting more realistic research.
Dr Erik Miljan, founding director of Simply Cells Ltd assesses the impact on the physiological relevance of in vitro cell based models using traditional ECM proteins, recombinant biomimetics hydrogels and other matrices like polystyrene scaffolds in drug discovery and disease modeling applications. Highlighting real examples including spheroid and neuronal stem cell culture, Dr Miljan demonstrates how different 3D technologies can be applied to specific needs of researchers.